-
Mashup Score: 0
Both pediatric brain cancers and sarcomas have an extremely dismal outcome in the relapse setting, according to Catherine Bollard, MD. A new Cancer Grand Challenge aims to address the issue with the development of new therapies.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
A biologics license application seeking the approval of remestemcel-L has been resubmitted to the FDA for the treatment of pediatric patients with steroid-refractory, acute graft-vs-host-disease.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Remestemcel-L BLA Resubmitted to FDA for Pediatric Steroid-Refractory aGVHD @US_FDA #pedcsm https://t.co/JKWaJnCiov
-
-
Mashup Score: 0FDA Grants Orphan Drug Exclusivity to Pedmark for Prevention of Platinum-Induced Ototoxicity in Pediatric Solid Tumors - 1 year(s) ago
The FDA has granted orphan drug exclusivity to sodium thiosulfate injection, which is indicated to reduce the risk of platinum-induced ototoxicity in pediatric patients 1 month of age and older with localized, non-metastatic solid tumors.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
FDA Grants Orphan Drug Exclusivity to Pedmark for Prevention of Platinum-Induced Ototoxicity in Pediatric Solid Tumors @US_FDA #pedcsm #oncology https://t.co/11SnNEwe34
-
-
Mashup Score: 0NCCN Recommends Sodium Thiosulfate to Reduce the Risk for Cisplatin-Induced Hearing Loss in Pediatric Patients - 1 year(s) ago
Fennec Pharmaceuticals announced an update to the National Comprehensive Cancer Network’s practice guidelines for Adolescent and Young Adult Oncology, calling for the use of sodium thiosulfate injection to reduce the risk for ototoxicity in pediatric patients receiving cisplatin.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Fennec Pharmaceuticals announced an update to the NCCN’s practice guidelines for Adolescent and Young Adult Oncology, calling for the use of sodium thiosulfate injection to reduce the risk for ototoxicity in pediatric patients receiving cisplatin. #pedcsm https://t.co/RierRyemBG
-
-
Mashup Score: 0NCCN Recommends Sodium Thiosulfate to Reduce the Risk for Cisplatin-Induced Hearing Loss in Pediatric Patients - 1 year(s) ago
Fennec Pharmaceuticals announced an update to the National Comprehensive Cancer Network’s practice guidelines for Adolescent and Young Adult Oncology, calling for the use of sodium thiosulfate injection to reduce the risk for ototoxicity in pediatric patients receiving cisplatin.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Fennec Pharmaceuticals announced an update to the NCCN’s practice guidelines for Adolescent and Young Adult Oncology, calling for the use of sodium thiosulfate injection to reduce the risk for ototoxicity in pediatric patients receiving cisplatin. #pedcsm https://t.co/xc6NZMQCqu https://t.co/TuYEV2Go28
-
-
Mashup Score: 1NCCN Recommends Sodium Thiosulfate to Reduce the Risk for Cisplatin-Induced Hearing Loss in Pediatric Patients - 1 year(s) ago
Fennec Pharmaceuticals announced an update to the National Comprehensive Cancer Network’s practice guidelines for Adolescent and Young Adult Oncology, calling for the use of sodium thiosulfate injection to reduce the risk for ototoxicity in pediatric patients receiving cisplatin.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
NCCN Recommends Sodium Thiosulfate to Reduce the Risk for Cisplatin-Induced Hearing Loss in Pediatric Patients #pedcsm #oncology https://t.co/vcR6wac9wN
-
-
Mashup Score: 0Late Radiation-Induced Carotid Artery Stenosis and Stroke in Pediatric Patient Treated with Proton Radiation Therapy for Skull Base Chordoma. - 1 year(s) ago
Radiation vasculopathy is a well-recognized late complication of radiation therapy (RT). We present a case of a stroke 29 years after high-dose proton RT for skull base chordoma due to occlusion of bilateral internal carotid arteries (ICA).
Source: Practical Radiation OncologyCategories: Hem/Oncs, Latest HeadlinesTweet-
A reminder that late complications after #radiotherapy can occur ... very late (there is no plateau for cumulative incidence)☢️ Knowledge of these, proper surveillance & early intervention, if possible, are important🚨 @ShannonMacDonMD #radonc #pedcsm https://t.co/4jSbAnLbjN
-
-
Mashup Score: 0Current Role and Future Potential of CSF ctDNA for the Diagnosis and Clinical Management of Pediatric Central Nervous System Tumors - 1 year(s) ago
Most pediatric central nervous system (CNS) tumors are located in eloquent anatomic areas, making surgical resection and, in some cases, even biopsy risky or impossible. This diagnostic predicament coupled with the move toward molecular classification for diagnosis has exposed an urgent need to develop a minimally invasive means to obtain diagnostic information. In non-CNS solid tumors, the…
Source: JNCCNCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Current Role and Future Potential of CSF ctDNA for the Diagnosis and Clinical Management of Pediatric CNS Tumors: https://t.co/BjIKL67mKz Review by Alexandra M. Miller, MD, PhD & Matthias A. Karajannis, MD, MS of @MSKCancerCenter #pedonc #pedcsm #CNScancer #childhoodcancer https://t.co/rjepXD12I4
-
-
Mashup Score: 0JNCCN - 1 year(s) ago
This site uses cookies, tags, and tracking settings to store information that help give you the very best browsing experience. Dismiss this warning
Source: JNCCNCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The December issue of @JNCCN is now available online! Featured: new @NCCN Guidelines on Pediatric CNS Cancers, Iisights into recent updates to #NCCNGuidelines for #ProstateCancer, and more! https://t.co/8t8aPaRYGu #pedcsm #CNScancer #BTSM #PCSM https://t.co/SAQBrv129H
-
-
Mashup Score: 0
Results from a pooled case control study indicate that meninges are very radiosensitive in pediatric patients who were treated at prior to age 10 years, supporting reduced dose whole brain irradiation in this population.
Source: Cancer NetworkCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Results from a pooled case control study indicate that meninges are very radiosensitive in pediatric patients who were treated at prior to age 10 years, supporting reduced dose whole brain irradiation in this population. #pedcsm https://t.co/IGAHjdVBjZ
-
Due to the fact pediatric #braincancers and #sarcomas have extremely dismal outcomes in the relapse setting, the Cancer Grand Challenge aims to address the issue with the development of new therapies. #pedcsm @theNCI @ChildrensNatl https://t.co/SaJ63NHiuI https://t.co/9usckj2VvE